FindTrial
Sign In

atrial fibrillation/flutter after atrial septal defect closure

Incidence and prognosis of atrial arrhythmia after atrial septal defect closure: percutaneous device closure vs open heart surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010486
Enrollment
27722
Registered
2025-05-20
Start date
2024-07-22
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have undergone percutaneous device or surgical closure for atrial septal defect

Exclusion criteria

Exclusion criteria: 1) Patients diagnosed with atrial fibrillation or atrial flutter before the closure procedure 2) Patients who underwent catheter ablation or cardioversion for atrial fibrillation or atrial flutter before the closure procedure (M6541, M6542, M6546, M6547, M0651, M0652, M5880) 3) Patients who underwent arrhythmia surgery during the closure procedure (O2006, O2007) 4) Patients who underwent surgery for congenital heart disease (Q20-28), excluding patent ductus arteriosus (Q25.5) or non-specific cardiac malformations (Q24.9)

Design outcomes

Primary

MeasureTime frame
Newly developed atrial fibrillation or atrial flutter—

Secondary

MeasureTime frame
Electrical cardioversion of atrial arrhythmia , Catheter ablation for atrial arrhythmia;Ischemic stroke, Death from any cause—

Countries

Korea, Republic of

Contacts

Public ContactJoong Min Lee

Asan Medical Center

lcm623@naver.com+82-2-3010-0546

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026